CVs now established as exit route alongside M&A and IPO: Moelis’s Hammer
Secondaries buyers’ own specialisation is aiding in GPs’ interest to consider a CV in tandem with other exit options, Moelis & Co managing director Jeff Hammer said at NEXUS 2026.
3 March 2026•2 mins read
SECONDARIES INVESTOR
Register to unlock this content
Daily global secondaries market news and intelligence- Curated insights to keep you ahead of GP-led and LP-led secondaries
- Faster, data-driven decision making powered by our AI interface, 'Ask PEI'
- Access to proprietary research and reports
- Selected fund performance and investor activity data
